Publications by authors named "Bomberger J"

Article Synopsis
  • Reproducibility is crucial in science as it boosts confidence in findings and enables comparison of data, yet evaluating it can be challenging, especially with RNA sequencing (RNA-seq) where multiple steps can introduce variance.
  • This study specifically examines the reproducibility of gene expression data from bacteria in cystic fibrosis models, utilizing samples from three labs and different sequencing pipelines to draw comparisons.
  • The results indicate high reproducibility of gene expression across labs, despite some variance introduced by different sequencing methods, with both pipelines detecting over 80% of the same differentially expressed genes, confirming the validity of RNA-seq data comparisons.
View Article and Find Full Text PDF

Laboratory models are central to microbiology research, advancing the understanding of bacterial physiology by mimicking natural environments, from soil to the human microbiome. When studying host-bacteria interactions, animal models enable investigators to examine bacterial dynamics associated with a host, and in the case of human infections, animal models are necessary to translate basic research into clinical treatments. Efforts toward improving animal infection models are typically based on reproducing host genotypes/phenotypes and disease manifestations, leaving a gap in how well the physiology of microbes reflects their behavior in a human host.

View Article and Find Full Text PDF
Article Synopsis
  • Elexacaftor/tezacaftor/ivacaftor (ETI) therapy has significantly improved cystic fibrosis (CF) treatment, yet its impact on sinus microbiota remains unknown.
  • A study involving 38 adults with CF and chronic rhinosinusitis examined sinus samples pre- and post-ETI using advanced sequencing methods.
  • Results showed that while total bacterial load and diversity didn't significantly change after ETI, certain bacterial species, including methicillin-resistant Staphylococcus aureus (MRSA), persisted, indicating the need for ongoing management of these pathogens in CF care.
View Article and Find Full Text PDF

Mucosa-associated biofilms are associated with many human disease states, but the host mechanisms promoting biofilm remain unclear. In chronic respiratory diseases like cystic fibrosis (CF), Pseudomonas aeruginosa establishes chronic infection through biofilm formation. P.

View Article and Find Full Text PDF
Article Synopsis
  • Phage therapy uses lytic bacteriophages to combat multidrug-resistant bacterial infections, showing significant success in Eastern Europe but limited research on its effects on human hosts.
  • Researchers investigated how lytic phages interact with airway epithelial cells, especially from a cystic fibrosis patient, revealing that these interactions depend on the properties of the phage and the environment.
  • The airway epithelium does not effectively internalize phages but responds to them by altering gene expression and releasing certain cytokines, suggesting that both phage and host factors should be considered for effective phage therapy.
View Article and Find Full Text PDF

Unlabelled: Today, more than 90% of people with cystic fibrosis (pwCF) are eligible for the highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy called elexacaftor/tezacaftor/ivacaftor (ETI) and its use is widespread. Given the drastic respiratory symptom improvement experienced by many post-ETI, clinical studies are already underway to reduce the number of respiratory therapies, including antibiotic regimens, that pwCF historically relied on to combat lung disease progression. Early studies suggest that bacterial burden in the lungs is reduced post-ETI, yet it is unknown how chronic populations are impacted by ETI.

View Article and Find Full Text PDF
Article Synopsis
  • Phage therapy utilizes lytic bacteriophages to combat multidrug resistant infections, showing promising results in Eastern Europe but lacking extensive data on human interactions.
  • The study investigates how lytic phages interact with airway epithelial cells, finding that these interactions vary based on phage properties and the microenvironment.
  • Results indicate that airway epithelial cells change their functions in response to phage exposure, which could influence the effectiveness of phage therapy in respiratory infections.
View Article and Find Full Text PDF

Background: While the widespread initiation of elexacaftor/tezacaftor/ivacaftor (ETI) has led to dramatic clinical improvements among persons with cystic fibrosis (pwCF), little is known about how ETI affects the respiratory mucosal inflammatory and physiochemical environment, or how these changes relate to lung function.

Methods: We performed a prospective, longitudinal study of adults with CF and chronic rhinosinusitis (CF-CRS) followed at our CF center (n = 18). Endoscopic upper respiratory tract (paranasal sinus) aspirates from multiple visit dates, both pre- and post-ETI initiation, were collected and tested for cytokines, metals, pH, and lactate levels.

View Article and Find Full Text PDF

Background: Alpha-1 antitrypsin deficiency (AATD) is the most common genetic risk factor for early-onset emphysema. However, AATD continues to be underrecognized and underdiagnosed. Provider awareness about AATD, concerns with testing costs, and limited understanding about therapeutic options contribute to its underdiagnosis.

View Article and Find Full Text PDF

Clinical studies report that viral infections promote acute or chronic bacterial infections at multiple host sites. These viral-bacterial co-infections are widely linked to more severe clinical outcomes. In experimental models in vitro and in vivo, virus-induced interferon responses can augment host susceptibility to secondary bacterial infection.

View Article and Find Full Text PDF
Article Synopsis
  • Miscommunication between antiviral and antibacterial signals during respiratory infections can worsen illness and increase death rates.
  • Extracellular vesicles (EVs), released from epithelial cells during antiviral responses, hinder the ability of macrophages to fight bacterial infections in the airway.
  • This study highlights how these EVs disrupt communication between epithelial cells and macrophages, leading to impaired immune responses and offering new insights into the challenges of immune dysfunction in respiratory coinfections.
View Article and Find Full Text PDF

This article reviews the role of outer membrane vesicles (OMVs) in mediating the interaction between Gram-negative bacteria and their human hosts. OMVs are produced by a diverse range of Gram-negative bacteria during infection and play a critical role in facilitating host-pathogen interactions without requiring direct cell-to-cell contact. This article describes the mechanisms by which OMVs are formed and subsequently interact with host cells, leading to the transport of microbial protein virulence factors and short interfering RNAs (sRNA) to their host targets, exerting their immunomodulatory effects by targeting specific host signaling pathways.

View Article and Find Full Text PDF

grows as a biofilm under many environmental conditions, and the bacterium can disperse from biofilms via highly regulated, dynamic processes. However, physiologic triggers of biofilm dispersal remain poorly understood. Based on prior literature describing dispersal triggered by forms of starvation, we tested bacterial respiratory inhibitors for biofilm dispersal in two models resembling chronic airway infections.

View Article and Find Full Text PDF

Laboratory models are critical to basic and translational microbiology research. Models serve multiple purposes, from providing tractable systems to study cell biology to allowing the investigation of inaccessible clinical and environmental ecosystems. Although there is a recognized need for improved model systems, there is a gap in rational approaches to accomplish this goal.

View Article and Find Full Text PDF

Purpose: Recognizing rare diseases (RDs) and initiating appropriate investigation and referral is critical for timely diagnosis. Unfortunately, patients with RDs experience significant diagnostic delays, potentially leading to inappropriate or harmful testing or treatment and disease progression.

Methods: A 14-question survey assessing clinician knowledge, experience, and educational needs in RDs was emailed to US and European Union Medscape member clinicians.

View Article and Find Full Text PDF

The cystic fibrosis (CF) respiratory tract harbors pathogenic bacteria that cause life-threatening chronic infections. Of these, Pseudomonas aeruginosa becomes increasingly dominant with age and is associated with worsening lung function and declining microbial diversity. We aimed to understand why P.

View Article and Find Full Text PDF

Coinfection with two notorious opportunistic pathogens, the Gram-negative and Gram-positive , dominates chronic pulmonary infections. While coinfection is associated with poor patient outcomes, the interspecies interactions responsible for such decline remain unknown. Here, we dissected molecular mechanisms of interspecies sensing between and .

View Article and Find Full Text PDF

Viral-bacterial coinfections of the respiratory tract have long been associated with worsened disease outcomes. Clinical and basic research studies demonstrate that these infections are driven via complex interactions between the infecting pathogens, microbiome, and host immune response, although how these interactions contribute to disease progression is still not fully understood. Research over the last decade shows that the gut has a significant role in mediating respiratory outcomes, in a phenomenon known as the "gut-lung axis.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic rhinosinusitis (CRS) is a significant but often overlooked condition in cystic fibrosis (CF) patients, with treatment of upper airway issues potentially improving lower airway health.
  • A study involving 27 adults with CF CRS identified that sinus microbial communities were unstable and often dominated by Pseudomonas aeruginosa and staphylococci, leading to unique and fluctuating compositions during periods of symptoms.
  • The research found that lower microbial diversity in the sinuses correlated with worse disease symptoms and increased inflammation markers (like IL-1β), highlighting a relationship between sinus health and overall respiratory disease in CF patients.
View Article and Find Full Text PDF
Article Synopsis
  • Staphylococcus aureus can worsen outcomes when it causes pneumonia following viral infections, like influenza, leading to a complex situation known as superinfection.
  • Research has investigated how cell wall-anchored proteins (CWAs) in S. aureus affect its virulence during single and superinfections, revealing that these proteins are critical for bacterial survival and lung damage.
  • A specific CWA, known as SasD, has been identified as a novel factor that reduces inflammation and bacterial burden in superinfections, providing insights into how S. aureus interacts with the immune system in the lungs.
View Article and Find Full Text PDF
Article Synopsis
  • Bacteriophage therapy shows promise as an alternative to antibiotics, but more characterized phages are needed.
  • Researchers collected 23 bacterial isolates related to cystic fibrosis and clinical infections and isolated over a dozen phages from hospital wastewater.
  • They characterized these phages using genomic techniques and tested their effectiveness against bacterial mutants and biofilms, highlighting the potential for tailored bacteriophage treatments.
View Article and Find Full Text PDF

Background: Shotgun sequencing of cultured microbial isolates/individual eukaryotes (whole-genome sequencing) and microbial communities (metagenomics) has become commonplace in biology. Very often, sequenced samples encompass organisms spanning multiple domains of life, necessitating increasingly elaborate software for accurate taxonomic classification of assembled sequences.

Results: While many software tools for taxonomic classification exist, SprayNPray offers a quick and user-friendly, semi-automated approach, allowing users to separate contigs by taxonomy (and other metrics) of interest.

View Article and Find Full Text PDF

Pseudomonas aeruginosa notoriously adapts to the airways of people with cystic fibrosis (CF), yet how infection-site biogeography and associated evolutionary processes vary as lifelong infections progress remains unclear. Here we test the hypothesis that early adaptations promoting aggregation influence evolutionary-genetic trajectories by examining longitudinal P. aeruginosa from the sinuses of six adults with CF.

View Article and Find Full Text PDF

A recent workshop titled "Developing Models to Study Polymicrobial Infections," sponsored by the Dartmouth Cystic Fibrosis Center (DartCF), explored the development of new models to study the polymicrobial infections associated with the airways of persons with cystic fibrosis (CF). The workshop gathered 35+ investigators over two virtual sessions. Here, we present the findings of this workshop, summarize some of the challenges involved with developing such models, and suggest three frameworks to tackle this complex problem.

View Article and Find Full Text PDF